Breast lumps epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (18 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Breast lumps}} | {{Breast lumps}} | ||
{{CMG}} | |||
{{CMG}}; {{AE}} {{S.M}} | |||
== Overview == | |||
The incidence rate of breast lumps is not particularly clear due to the fact that [[breast lumps]] is not considered as a life threatening condition and majority of the women who receives medical therapies or surgeries come into account.The prevalence of [[benign]] breast disease is approximately 68% among all breast diseases and the incidence of breast diseases is higher on the left upper/outer quadrant of breast. [[Fibrocystic Disease|Fibrocystic diseases]] are more frequent in age of 40-44 years and [[fibroadenoma]] is more frequent between 15-35 years. [[Fibroadenoma]] rate is higher in black women. African-American women have worse [[prognosis]] and higher [[mortality rate]] in comparison European American women. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
* | ===Incidence=== | ||
* | *The incidence rate of benign breast disease is unclear due to the fact that [[breast lumps]] is not considered as a life threatening condition.<ref name="pmid9494790">{{cite journal| author=Goehring C, Morabia A| title=Epidemiology of benign breast disease, with special attention to histologic types. | journal=Epidemiol Rev | year= 1997 | volume= 19 | issue= 2 | pages= 310-27 | pmid=9494790 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9494790 }} </ref> | ||
* | *Majority of the women who receives medical therapies or surgeries come into account. | ||
* | *Particular detection rate is unknown and not estimated. | ||
* [[ | |||
===Prevalence=== | |||
* | *The prevalence of [[benign]] breast disease is approximately 68% among all breast diseases.<ref name="MRao2016">{{cite journal|last1=M|first1=Dr. Vijayalakshmi|last2=Rao|first2=Dr. J Yadigiri|last3=Shekar|first3=Dr. T.Y.|last4=Balakrishnan|first4=Dr. Shobha|last5=M|first5=Dr. Divya|last6=K|first6=Dr. Sameera|last7=N|first7=Dr. Alekya|last8=JVNK|first8=Dr. Aravind|title=Prevalence of Benign Breast Disease and Risk of Malignancy in Benign Breast Diseases|journal=IOSR Journal of Dental and Medical Sciences|volume=15|issue=08|year=2016|pages=32–36|issn=22790861|doi=10.9790/0853-1508083236}}</ref> | ||
*:* | *Approximately 60% of [[benign]] breast diseases occur in left breast and 40% in the right breast. | ||
== | *100% of definite palpable lumps are characteristics of [[fibroadenoma]], [[phyllodes tumor]], and adenomyoepithelioma. | ||
{{ | *64% of lumps located in upper outer quadrant, 26% of lumps in lower outer quadrant, 10% of lumps in upper inner quadrant. | ||
===Age=== | |||
Age-specific incidence rate of benign breast diseases.<ref name="pmid9494790">{{cite journal| author=Goehring C, Morabia A| title=Epidemiology of benign breast disease, with special attention to histologic types. | journal=Epidemiol Rev | year= 1997 | volume= 19 | issue= 2 | pages= 310-27 | pmid=9494790 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9494790 }} </ref> | |||
*The incidence rate of [[fibrocystic disease]] is 137 per 100,000 in women aged 25-29 years, 411 per 100,000 in age of 40-44 years and 387 per 100,000 in 45-49 years. | |||
*<nowiki/>The incidence rate of [[Fibroadenoma|fibroadenom]]<nowiki/>[[Fibroadenoma|a]] is 115 per 100,000 in women aged 20-24 years. | |||
*The peak incidence rate of [[fibroadenoma|fibroa]]<nowiki/>[[fibroadenoma|denoma]] is between 15-35 years.<ref name="pmid2890912">{{cite journal| author=Hughes LE, Mansel RE, Webster DJ| title=Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders. | journal=Lancet | year= 1987 | volume= 2 | issue= 8571 | pages= 1316-9 | pmid=2890912 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2890912 }} </ref> | |||
*[[Fibrocystic disease]], [[phyllodes tumor]], and adenomyoepithelioma are usually seen in 3rd and 4th decade of life.<ref name="MRao2016" /> | |||
===Race=== | |||
*African American women have worse [[prognosis]] and higher [[mortality rate]] in comparison to European American women.<ref name="pmid29188479">{{cite journal| author=Gupta V, Haque I, Chakraborty J, Graff S, Banerjee S, Banerjee SK| title=Racial disparity in breast cancer: can it be mattered for prognosis and therapy. | journal=J Cell Commun Signal | year= 2018 | volume= 12 | issue= 1 | pages= 119-132 | pmid=29188479 | doi=10.1007/s12079-017-0416-4 | pmc=5842180 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29188479 }}</ref> | |||
*European American women have higher incidence rate of [[Breast cancer|breast cancers]]. | |||
*The prevalence of [[fibroadenoma]] is higher in black women than white individuals.<ref name="pmid453472">{{cite journal| author=Oluwole SF, Freeman HP| title=Analysis of benign breast lesions in blacks. | journal=Am J Surg | year= 1979 | volume= 137 | issue= 6 | pages= 786-9 | pmid=453472 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=453472 }} </ref> | |||
==References== | |||
{{Reflist|2}} | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Gynecology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 20:42, 29 July 2020
|
Breast lumps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Breast lumps epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Breast lumps epidemiology and demographics |
|
Risk calculators and risk factors for Breast lumps epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
The incidence rate of breast lumps is not particularly clear due to the fact that breast lumps is not considered as a life threatening condition and majority of the women who receives medical therapies or surgeries come into account.The prevalence of benign breast disease is approximately 68% among all breast diseases and the incidence of breast diseases is higher on the left upper/outer quadrant of breast. Fibrocystic diseases are more frequent in age of 40-44 years and fibroadenoma is more frequent between 15-35 years. Fibroadenoma rate is higher in black women. African-American women have worse prognosis and higher mortality rate in comparison European American women.
Epidemiology and Demographics
Incidence
- The incidence rate of benign breast disease is unclear due to the fact that breast lumps is not considered as a life threatening condition.[1]
- Majority of the women who receives medical therapies or surgeries come into account.
- Particular detection rate is unknown and not estimated.
Prevalence
- The prevalence of benign breast disease is approximately 68% among all breast diseases.[2]
- Approximately 60% of benign breast diseases occur in left breast and 40% in the right breast.
- 100% of definite palpable lumps are characteristics of fibroadenoma, phyllodes tumor, and adenomyoepithelioma.
- 64% of lumps located in upper outer quadrant, 26% of lumps in lower outer quadrant, 10% of lumps in upper inner quadrant.
Age
Age-specific incidence rate of benign breast diseases.[1]
- The incidence rate of fibrocystic disease is 137 per 100,000 in women aged 25-29 years, 411 per 100,000 in age of 40-44 years and 387 per 100,000 in 45-49 years.
- The incidence rate of fibroadenoma is 115 per 100,000 in women aged 20-24 years.
- The peak incidence rate of fibroadenoma is between 15-35 years.[3]
- Fibrocystic disease, phyllodes tumor, and adenomyoepithelioma are usually seen in 3rd and 4th decade of life.[2]
Race
- African American women have worse prognosis and higher mortality rate in comparison to European American women.[4]
- European American women have higher incidence rate of breast cancers.
- The prevalence of fibroadenoma is higher in black women than white individuals.[5]
References
- ↑ 1.0 1.1 Goehring C, Morabia A (1997). "Epidemiology of benign breast disease, with special attention to histologic types". Epidemiol Rev. 19 (2): 310–27. PMID 9494790.
- ↑ 2.0 2.1 M, Dr. Vijayalakshmi; Rao, Dr. J Yadigiri; Shekar, Dr. T.Y.; Balakrishnan, Dr. Shobha; M, Dr. Divya; K, Dr. Sameera; N, Dr. Alekya; JVNK, Dr. Aravind (2016). "Prevalence of Benign Breast Disease and Risk of Malignancy in Benign Breast Diseases". IOSR Journal of Dental and Medical Sciences. 15 (08): 32–36. doi:10.9790/0853-1508083236. ISSN 2279-0861.
- ↑ Hughes LE, Mansel RE, Webster DJ (1987). "Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders". Lancet. 2 (8571): 1316–9. PMID 2890912.
- ↑ Gupta V, Haque I, Chakraborty J, Graff S, Banerjee S, Banerjee SK (2018). "Racial disparity in breast cancer: can it be mattered for prognosis and therapy". J Cell Commun Signal. 12 (1): 119–132. doi:10.1007/s12079-017-0416-4. PMC 5842180. PMID 29188479.
- ↑ Oluwole SF, Freeman HP (1979). "Analysis of benign breast lesions in blacks". Am J Surg. 137 (6): 786–9. PMID 453472.